title: Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.
authors.affiliation: Elan Pharmaceuticals, Inc., South San Francisco, CA 94080, USA. jesse.cedarbaum@elan.com
authors.forename: J M
authors.initials: JM
authors.lastname: Cedarbaum
authors.forename: G
authors.initials: G
authors.lastname: Crans
authors.forename: M
authors.initials: M
authors.lastname: Grundman
mesh_terms: D000465:Algorithms; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy; D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic / Q000379:methods*; D003072:Cognition Disorders / Q000175:diagnosis; D018450:Disease Progression; D006801:Humans; D018579:Patient Selection; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers